Logo image of MRT

MARTI TECHNOLOGIES INC (MRT) Stock Fundamental Analysis

NYSEARCA:MRT - NYSE Arca - US5731341039 - Common Stock - Currency: USD

2.4  -0.02 (-0.83%)

After market: 2.38 -0.02 (-0.83%)

Fundamental Rating

1

Taking everything into account, MRT scores 1 out of 10 in our fundamental rating. MRT was compared to 40 industry peers in the Ground Transportation industry. MRT has a bad profitability rating. Also its financial health evaluation is rather negative. MRT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year MRT has reported negative net income.
MRT had a negative operating cash flow in the past year.
MRT had negative earnings in each of the past 5 years.
In the past 5 years MRT always reported negative operating cash flow.
MRT Yearly Net Income VS EBIT VS OCF VS FCFMRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

Looking at the Return On Assets, with a value of -183.73%, MRT is doing worse than 95.00% of the companies in the same industry.
Industry RankSector Rank
ROA -183.73%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MRT Yearly ROA, ROE, ROICMRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -0.5 -1 -1.5

1.3 Margins

MRT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MRT Yearly Profit, Operating, Gross MarginsMRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 -100 -200 -300

More info and screens

2

2. Health

2.1 Basic Checks

MRT does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for MRT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MRT Yearly Shares OutstandingMRT Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 10M 20M 30M 40M
MRT Yearly Total Debt VS Total AssetsMRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 50M 100M

2.2 Solvency

MRT has an Altman-Z score of -5.40. This is a bad value and indicates that MRT is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -5.40, MRT is not doing good in the industry: 90.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.4
ROIC/WACCN/A
WACC9.5%
MRT Yearly LT Debt VS Equity VS FCFMRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 1.47 indicates that MRT should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.47, MRT is in the better half of the industry, outperforming 72.50% of the companies in the same industry.
A Quick Ratio of 1.32 indicates that MRT should not have too much problems paying its short term obligations.
MRT has a better Quick ratio (1.32) than 67.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 1.32
MRT Yearly Current Assets VS Current LiabilitesMRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2M 4M 6M 8M 10M

More info and screens

3

3. Growth

3.1 Past

MRT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -87.39%.
MRT shows a decrease in Revenue. In the last year, the revenue decreased by -6.84%.
EPS 1Y (TTM)-87.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-87.39%
Revenue 1Y (TTM)-6.84%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-48.82%

3.2 Future

Based on estimates for the next years, MRT will show a very strong growth in Earnings Per Share. The EPS will grow by 45.38% on average per year.
The Revenue is expected to grow by 77.32% on average over the next years. This is a very strong growth
EPS Next Y51.77%
EPS Next 2Y45.38%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year104.66%
Revenue Next 2Y109.92%
Revenue Next 3Y88.82%
Revenue Next 5Y77.32%

3.3 Evolution

MRT Yearly Revenue VS EstimatesMRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 50M 100M 150M
MRT Yearly EPS VS EstimatesMRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0 -0.2 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

MRT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year MRT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MRT Price Earnings VS Forward Price EarningsMRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MRT Per share dataMRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1

4.3 Compensation for Growth

A more expensive valuation may be justified as MRT's earnings are expected to grow with 45.38% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.38%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MRT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MARTI TECHNOLOGIES INC

NYSEARCA:MRT (8/11/2025, 8:04:02 PM)

After market: 2.38 -0.02 (-0.83%)

2.4

-0.02 (-0.83%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryGround Transportation
Earnings (Last)04-29 2025-04-29/bmo
Earnings (Next)09-29 2025-09-29
Inst Owners13.06%
Inst Owner Change0%
Ins Owners34.39%
Ins Owner Change0%
Market Cap182.98M
Analysts77.78
Price Target5.25 (118.75%)
Short Float %0.17%
Short Ratio0.8
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.72%
PT rev (3m)-0.72%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.33%
Revenue NY rev (3m)0.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.81
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.25
EYN/A
EPS(NY)-0.34
Fwd EYN/A
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.33
OCFYN/A
SpS0.24
BVpS-0.43
TBVpS-0.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -183.73%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 11.96%
Cap/Sales 5.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.47
Quick Ratio 1.32
Altman-Z -5.4
F-Score5
WACC9.5%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-87.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-87.39%
EPS Next Y51.77%
EPS Next 2Y45.38%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.84%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-48.82%
Revenue Next Year104.66%
Revenue Next 2Y109.92%
Revenue Next 3Y88.82%
Revenue Next 5Y77.32%
EBIT growth 1Y-118.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year107.85%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-32.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-68.69%
OCF growth 3YN/A
OCF growth 5YN/A